# Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

> **NCT00020787** · PHASE3 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer

## Interventions

- **BIOLOGICAL:** G17DT Immunogen
- **DRUG:** cisplatin
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00020787
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2002-01
- **Final completion:** 2002-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020787, "Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00020787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*